Authors


Lina Meng, PharmD, BCIDP, BCCCP

Latest:

Vancomycin AUC Implementation in Resource-Limited Settings and its Associated Difficulties

The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.


Patricia Pecora Fulco, PharmD, BCPS, FASHP, AAHIVP

Latest:

Multidrug Resistance in a Patient With HIV

In this case study, clinicians review a challenging case.


Marissa Walsh, PharmD, BCPS, BCIDP, DPLA

Latest:

Daptomycin Resistance Among Enterococci Is a Growing Antimicrobial Resistance Threat

In a world heavily focused on therapeutic options for multidrug-resistant gram-negative organisms, the emergence of antimicrobial resistance among enterococci is often an under-recognized risk.


Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc

Latest:

Measles: An Old Foe Has Returned

Texas is experiencing its largest measles outbreak in 30 years and the Centers for Disease Control and Prevention's (CDC) Epidemic Intelligence Service is providing support there. Here is an overview on testing, disease presentation, and vaccination, as well as commentary on the public health impact of vaccine hesitancy, and the unintended consequences of the immunization program’s success.


Beatriz Mothe, MD, PhD

Latest:

Initial Findings from IMC-M113V Trial for HIV Functional Cure Strategy Shows Potential

Beatriz Mothe, MD, PhD discusses the Phase 1/2 STRIVE trial of IMC-M113V, a T cell receptor bispecific therapy targeting HIV-infected cells


Joy Uzoma, PharmD, BCIDP

Latest:

Penicillin and Syphilis Treatment: Sole Option or One of a Few?

Penicillin continues to be an important therapy for treating syphilis. Here is a review of the literature in comparing one of the first antibiotics to non-penicillin treatments for non-neurological syphilis.


Sylvia Ou, PharmD

Latest:

A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.


Conan MacDougall, PharmD, MAS, BCPS, BCIDP

Latest:

Children, COVID-19, and Another Crazy Respiratory Viral Season

Kevin J. Downes, MD, and Contagion® Section Editor Conan MacDougall, PharmD, MAS, BCPS, BCIDP, discuss these important topics as another season approaches.



David Berman, MD, PhD

Latest:

Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial

David Berman, MD, PhD, discusses signs of dose-dependent viral control and reduction in active HIV reservoir in Phase 1/2 STRIVE trial data.


Nilu Goonetilleke, LLBHons, BScHons, PhD

Latest:

The CM Study: Bivalent HIV Vaccine Induces Stronger T Cell Responses in People with HIV on ART

Nilu Goonetilleke, LLBHons, BScHons, PhD, presents findings showing the bivalent HIVconsvX vaccine targets both Mosaic-1 and Mosaic-2, resulting in broader immune responses.


Leslie McGorman, MPPA

Latest:

Political and Social Barriers to Ending the HIV Epidemic

Learning about these barriers is the first step to overcoming them.


Timothy Gauthier, PharmD, BCPS, BCIDP

Latest:

5 Ways Pharmacists Can Use Social Media For Professional Advancement

Social media involves information and content sharing and pharmacists can utilize the various platforms to enhance their professional needs and resources for their careers.


Alemnew Dagnew, MD, MSc, MVPCD, MPH, FRSPH

Latest:

A Late-Stage Tuberculosis Vaccine is Making its Way Through Clinical Trials

Monday is World Tuberculosis (TB) Day, and a vaccine developed by the Gates Medical Research Institute is being studied in a phase 3 trial. If approved, the vaccine could potentially prevent pulmonary TB in adults and adolescents.


Christina Yen, MD

Latest:

CRAB-By No More?

Understanding the potential and limitations of new Acinetobacter baumannii active therapies.


Kevin Kavanagh, MD

Latest:

A Comparative Analysis Show Distinct Severity of COVID-19 vs Influenza

Results of a study by Yan Xie and colleagues highlight the severe impact of COVID-19, with higher death rates, increased risks of long-term complications, and greater infectivity compared to seasonal influenza.


Uzma Syed, MD, DO

Latest:

Addressing Antimicrobial Resistance in Women

Uzma Syed, MD, DO discussed how various factors increase women’s susceptibility to AMR, the importance of policies, and the need for culturally specific education and advocacy to improve health outcomes.


Gordon Ramage, BSc, PhD

Latest:

Fungal Biofilm-Related Diseases: Diagnosis, Treatment, and Emerging Challenges

Professor Gordon Ramage, BSc, PhD, discusses the increasing impact of fungal biofilms, new treatment options, and the need for enhanced detection methods.



Amanda M. Casto, MD, PhD

Latest:

Analyzing Household Transmission of COVID-19

At ID Week 2024, an investigator, Amanda M. Casto, MD, PhD, discusses her work on the CASCADIA study, which examined infection rates in this setting, and how it challenged assumptions that there is likely a singular carrier bringing viruses into homes.


Caryn Fenner

Latest:

Timeline for mRNA Vaccine Development for Rift Valley Fever

Caryn Fenner and Petro Terblanche outline Afrigen's clinical trial plans, local partnerships, and vaccine pipeline.


William Schaffner, MD

Latest:

Final Thoughts on COVID-19 and Flu

Final thoughts from experts on controlling COVID-19 and influenza.


Ryan Mynatt, PharmD, BCPS

Latest:

Tricky Infusion Issues and Potential Solutions: OPAT Edition

Outpatient parenteral antimicrobial therapy (OPAT) offers benefits for patients as well as providing cost effectiveness; however, it is not without its challenges. Two clinicians provide insights on this modality.


Harmony Garges, MD, MPH

Latest:

Apretude PrEP Shows High Efficacy, Safety in Diverse Studies

New data at CROI 2025 shows zero cases of HIV acquisition reported with Apretude (cabotegravir long-acting (CAB LA) for PrEP in varied clinical settings and populations in 2 implementation studies in the US and Brazil.


Deema Abdelrahman, PharmBSc, BCIDP

Latest:

Antimicrobial Stewardship: How to Extend a Solid Handshake

In the latest column from SIDP, handshake stewardship prioritizes face-to-face communication between frontline providers to enable feedback to assess the appropriateness of prescribed antimicrobials.


Evelyn Wu, MD

Latest:

Expanding Tick-Borne Disease Trends in New Jersey

Evelyn Wu, MD, reveals a rise in tick-borne diseases in New Jersey over the past two decades and correlations with the influence of warming climate conditions.


Nicole Bradley, PharmD, BCPS, BCIDP

Latest:

Shifting to Shorter Courses of Antibiotic Therapy for Common Pediatric Infections

In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.


Stephen Pagkalinawan, MD

Latest:

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Cytomegalovirus Infection

There have been sporadic cases Hemophagocytic Lymphohistiocytosis, associated with Cytomegalovirus Infection infection, suggesting that CMV may cause clinically significant disease beyond mononucleosis in immunocompetent individuals.



Esther Y. Bae, PharmD, BCIDP

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.

© 2025 MJH Life Sciences

All rights reserved.